Search Orphan Drug Designations and Approvals
-
Generic Name: | Ombitasvir/Paritaprevir/Ritonavir |
---|---|
Date Designated: | 02/24/2016 |
Orphan Designation: | Treatment of pediatric patients with chronic hepatitis C virus infection |
Orphan Designation Status: | Designated/Withdrawn |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AbbVie Inc. 1 North Waukegan Road North Chicago, Illinois 60064 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-